INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC N-SUBSTITUTED PIPERAZINE DERIVATIVES
    7.
    发明申请
    INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC N-SUBSTITUTED PIPERAZINE DERIVATIVES 有权
    吲哚,氮杂和相关杂环N-取代的哌嗪衍生物

    公开(公告)号:US20080132516A1

    公开(公告)日:2008-06-05

    申请号:US12028189

    申请日:2008-02-08

    摘要: This invention provides compounds of Formula I, including pharmaceutically acceptable salts thereof, having drug and bio-affecting properties, their pharmaceutical compositions and method of use. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. The compounds of Formula I have the formula wherein: Z is Q is selected from the group consisting of m is 2; A is selected from the group consisting of cinnolinyl, napthyridinyl, quinoxalinyl, pyridinyl, pyrimidinyl, quinolinyl, isoquinolinyl, quinazolinyl, azabenzofuryl, and phthalazinyl each of which may be optionally substituted with one or two groups independently selected from methyl, methoxy, hydroxy, amino and halogen; and —W— is

    摘要翻译: 本发明提供具有药物和生物影响性质的式I化合物,包括其药学上可接受的盐,其药物组合物和使用方法。 这些化合物具有独特的抗病毒活性,无论是单独使用还是与其他抗病毒药,抗感染剂,免疫调节剂或HIV进入抑制剂组合使用。 更具体地说,本发明涉及艾滋病毒和艾滋病的治疗。 式I的化合物具有下式:其中:Z为Q选自m为2; A选自噌啉基,萘啶基,喹喔啉基,吡啶基,嘧啶基,喹啉基,异喹啉基,喹唑啉基,氮杂苯并呋喃基和酞嗪基,其各自可以任选被一个或两个独立地选自甲基,甲氧基,羟基,氨基 和卤素; 和-W-是

    Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
    9.
    发明授权
    Indole, azaindole and related heterocyclic N-substituted piperazine derivatives 有权
    吲哚,氮杂吲哚和相关杂环N-取代的哌嗪衍生物

    公开(公告)号:US08039486B2

    公开(公告)日:2011-10-18

    申请号:US12028189

    申请日:2008-02-08

    IPC分类号: A61K31/04 C07D215/38

    摘要: This invention provides compounds of Formula I, including pharmaceutically acceptable salts thereof, having drug and bio-affecting properties, their pharmaceutical compositions and method of use. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. The compounds of Formula I have the formula wherein: Z is Q is selected from the group consisting of m is 2; A is selected from the group consisting of cinnolinyl, napthyridinyl, quinoxalinyl, pyridinyl, pyrimidinyl, quinolinyl, isoquinolinyl, quinazolinyl, azabenzofuryl, and phthalazinyl each of which may be optionally substituted with one or two groups independently selected from methyl, methoxy, hydroxy, amino and halogen; and —W— is

    摘要翻译: 本发明提供具有药物和生物影响性质的式I化合物,包括其药学上可接受的盐,其药物组合物和使用方法。 这些化合物具有独特的抗病毒活性,无论是单独使用还是与其他抗病毒药,抗感染剂,免疫调节剂或HIV进入抑制剂组合使用。 更具体地说,本发明涉及艾滋病毒和艾滋病的治疗。 式I的化合物具有下式:其中:Z为Q选自m为2; A选自噌啉基,萘啶基,喹喔啉基,吡啶基,嘧啶基,喹啉基,异喹啉基,喹唑啉基,氮杂苯并呋喃基和酞嗪基,其各自可以任选被一个或两个独立地选自甲基,甲氧基,羟基,氨基 和卤素; 和-W-是